IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

FDA issues warning letter to RPG Life Sciences API plant in India

8:56 PM MDT | June 25, 2013 | Deepti Ramesh

FDA issued a warning letter late last month to the active pharmaceutical ingredient (API) and finished pharmaceutical manufacturing facilities of RPG Life Sciences (Mumbai)—located at Navi Mumbai and Ankleshwar, India, respectively—for violations of cGMP. The warning letter was recently published on the FDA Web site. An FDA inspections, from 28–31 January 2013 at the Navi Mumbai API facility and from 20–24 November 2012 at the Ankleshwar finished pharmaceuticals facility, identified significant deviations from cGMP for the manufacture of...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa